Wave Achieves First Therapeutic RNA Editing in Humans
The company’s share price has rocketed after becoming the first to show RNA editing works in humans, providing new competition for gene-editing firms.
The company’s share price has rocketed after becoming the first to show RNA editing works in humans, providing new competition for gene-editing firms.